Internal Medicine, Hematology & Oncology · Johnson City, TN
NPI
1003807355
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
302 Wesley St Ste 3
Johnson City, TN, 37601
Phone (423) 202-3772
Groups this clinician bills Medicare through
Medicare paid, 2024
$183K
58,899 services
Medicare patients, 2024
225
Average age 71
Drug cost, 2024
$6.0M
3,483 prescriptions
Company payments, 2024
$144
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles Famoyin was code J1071 (injection, testosterone cypionate, 1 mg), 44,801 times for 15 patients. In total Charles Famoyin billed 58,899 services in 67 codes, and Medicare paid $183K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 44,801 | 15 | $0.02 | $814 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 3,628 | 73 | $0.07 | $260 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,898 | 64 | $0.08 | $159 |
| 99214 Office E&M - Established | Office | 1,099 | 216 | $76.37 | $84K |
| 36415 Venipuncture Blood Collection | Office | 884 | 200 | $8.46 | $7,474 |
| 96372 Injection Administration | Office | 561 | 102 | $8.61 | $4,828 |
| 96375 Injection Administration | Office | 546 | 72 | $9.47 | $5,172 |
| 96365 Intravenous Infusion, Hydration | Office | 513 | 73 | $37.97 | $19K |
| 96367 Intravenous Infusion, Hydration | Office | 458 | 71 | $17.82 | $8,163 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 453 | 65 | $0.50 | $228 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 415 | 69 | $0.62 | $258 |
| 96366 Intravenous Infusion, Hydration | Office | 394 | 64 | $12.67 | $4,994 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 228 | 55 | $0.90 | $206 |
| 80305 Drug Tests | Office | 135 | 31 | $11.98 | $1,618 |
| J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 87 | 20 | $0.01 | $0.83 |
By year: 2022 $239K for 45,003 services; 2023 $234K for 60,915 services; 2024 $183K for 58,899 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 884 | 200 | $8.46 | $7,474 |
| 80305 Drug Tests | 135 | 31 | $11.98 | $1,618 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles Famoyin prescribed most often to Medicare patients was Privigen (Immun Glob G(Igg)/Pro/Iga 0-50), with 283 prescriptions and refills. In total Charles Famoyin wrote 3,483 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 283 | 318 | 48 | $1.4M |
| Gabapentin Generic | 169 | 169 | 41 | $1,988 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 151 | 151 | 30 | $4,043 |
| Folic Acid Generic | 149 | 329 | 67 | $906 |
| Prednisone Generic | 107 | 129 | 59 | $375 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 104 | 104 | 21 | $3,032 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 90 | 106 | 15 | $297K |
| Oxycodone Hcl Generic | 86 | 86 | 19 | $2,379 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 73 | 84 | 37 | $311 |
| Tramadol Hcl Generic | 68 | 68 | 14 | $2,280 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 65 | 65 | 51 | $618 |
| Ondansetron Hcl Generic | 57 | 58 | 30 | $1,853 |
| Eliquis Apixaban | 57 | 100 | 18 | $59K |
| Warfarin Sodium Generic | 55 | 121 | 11 | $466 |
| Gammaked Immune Globul G/Gly/Iga Avg 46 | 50 | 60 | 12 | $250K |
Brand drugs: - claims; generic drugs: 2,480 claims; opioid claims: 485.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Charles Famoyin $144 ($144 in general payments such as food, travel and fees) from 3 companies. The largest payer was Adc Therapeutics America, Inc. with $63.24.
| Company | Payments | Amount |
|---|---|---|
| Adc Therapeutics America, Inc. | 1 | $63.24 |
| Accord Healthcare, Inc. | 2 | $48.52 |
| Pfizer Inc. PFE | 2 | $31.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.